Lilly reports on late-stage diabetes drug studies

October 22, 2012 at 07:59 AM
Share & Print

More From HR Executive

NOT FOR REPRINT

© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Related Stories

Hospital stays, specialty drugs drive high-cost claims Rethinking benefits: What if we paid members to get healthy? ICHRA adaption has gone mainstream as a benefits strategy Digital health care now a way of life for American consumers The $35 prescription cliff: Fill rates collapse as costs rise Maryland proposes price cap on Ozempic